Target intelligence / Profile preview

Cellular membranes and membrane-associated proteins

Molecular classification
Receptor, Ion channel, Transporter, Enzyme, Other
01

Overview

Cellular membranes and membrane-associated proteins represent the structural and functional interfaces of biological cells, consisting of a phospholipid bilayer embedded with diverse proteins (StatPearls, 2023). These proteins, which include receptors, ion channels, and transporters, are essential for maintaining cellular homeostasis, facilitating signal transduction, and regulating the transport of ions and molecules (PubMed, 2021). It is estimated that approximately 30% of the human proteome consists of membrane proteins, and they account for more than 50% of all current therapeutic drug targets (Nature Reviews Drug Discovery, 2006). Because they are involved in nearly every physiological process, their dysfunction is linked to a wide range of pathologies, including oncogenesis, cardiovascular diseases, and neurological disorders (NIH, 2022). Drugs targeting these components often work by agonizing or antagonizing receptors, blocking or opening ion channels, or inhibiting membrane-bound enzymes (PubChem, 2023). However, targeting these proteins can be challenging due to their complex hydrophobic nature and the potential for off-target effects in non-diseased tissues where these proteins may also be expressed (PubMed, 2020).

Other names
Biological membranesPlasma membraneMembrane proteinsIntegral membrane proteinsPeripheral membrane proteins
02

Mechanism of action

Drugs targeting this category act by binding to specific integral or peripheral proteins to modulate signaling cascades, regulate ion flux, inhibit enzymatic activity, or alter membrane permeability and lipid composition (PubChem, 2023).

03

Biological functions

Signal transductionTransportCell adhesionCell-cell communicationMetabolismStructural integrity
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInfectionMetabolic disorder
05

Safety considerations

Systemic toxicity due to widespread expressionOff-target interactions within protein familiesDisruption of membrane potentialLipid metabolism interference
06

Interacting drugs

Amlodipine

4 more in the full profile.

07

Biomarkers

HER2 expressionEGFR mutation statusLDL cholesterol levels

Beyond the preview

Go deeper on Cellular membranes and membrane-associated proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular membranes and membrane-associated proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call